Core summary of product characteristics for human plasma-derived hepatitis B immunoglobulin for intravenous use

  • Email
  • Help
Current effective version

Adopted guideline

Reference numberCPMP/BPWG/4027/02
Published27/04/2006
Effective from01/11/2006
KeywordsHepatitis B immunoglobulin, summary of product characteristics (SPC)
DescriptionThis document describes the information to be included in the summary of product characteristics for human hepatitis B immunoglobulin for intravenous administration.


Related content


How helpful is this page?

Average rating:

 Based on 0 ratings

Add your rating:

See all ratings
0 ratings
0 ratings
0 ratings
0 ratings
0 ratings
    

Tell us more